British drugmaker GlaxoSmithKline said Friday U.S. regulators approved its vaccine Cervarix to prevent the leading cause of cervical cancer in women.
cervical cancerGlaxoSmithKline says HPV vaccine worked in studyNewsvine - business Tue, 07/07/2009 - 11:37
Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease. Tags:
|
